Deuterated etifoxine
| Clinical data | |
|---|---|
| Other names | Etifoxine deuterated; GRX-917 |
| Routes of administration | Oral administration |
| Drug class | GABAA receptor positive allosteric modulator; TSPO ligand |
Deuterated etifoxine (developmental code name GRX-917) is a deuterated drug which is under development for the treatment of anxiety disorders and mood disorders.